Semaglutide and Hair Loss: Is It the Drug or the Weight Loss?
Reviewed by Peptide Nerds Editorial · Updated March 2026
Semaglutide and Hair Loss: Is It the Drug or the Weight Loss?
Key takeaways:
- Alopecia (hair loss) was reported in approximately 3% of patients in semaglutide clinical trials versus 1% on placebo
- The most likely cause is telogen effluvium -- a temporary hair shedding condition triggered by rapid weight loss, caloric restriction, and nutritional stress
- The same pattern occurs after bariatric surgery, crash diets, and other rapid weight loss events
- Hair loss typically begins 3-6 months after significant weight loss starts and is usually temporary, resolving within 6-12 months
- Adequate protein, iron, zinc, and biotin intake during weight loss can help reduce severity
Important: This article is for educational purposes only. It is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider if you are experiencing hair loss. See our full medical disclaimer.
The question everyone asks
You have been on semaglutide for a few months. The weight is coming off. You are feeling good. Then you notice more hair in the shower drain, on your pillow, in your brush. The question hits: is this the medication?
It is one of the most searched concerns about semaglutide, and the answer is more nuanced than "yes" or "no." Here is what the clinical data shows, what the likely mechanism is, and what you can do about it.
What the clinical trial data says
In the STEP 1 trial (PMID: 33567185), alopecia was reported as an adverse event in approximately 3% of patients taking semaglutide 2.4mg compared to roughly 1% in the placebo group. This difference is statistically notable but modest.
Across the broader STEP program (STEP 1 through STEP 5), hair loss was consistently reported at low single-digit percentages. It was never among the most common side effects -- nausea, diarrhea, vomiting, and constipation dominated those lists.
However, clinical trial adverse event reporting likely underestimates the true prevalence. Patients in trials report what they are asked about or what they consider significant enough to mention. Hair shedding that is noticeable but not dramatic may go unreported. Post-marketing surveillance and patient communities suggest that the actual rate of noticeable hair thinning may be higher than the 3% reported in trials.
Tirzepatide trials (SURMOUNT program) reported similar low rates of alopecia. This is a GLP-1-class pattern, not a semaglutide-specific one.
The real culprit: telogen effluvium
The leading explanation for hair loss on semaglutide is not a direct pharmacological effect of the drug. It is telogen effluvium -- a well-characterized, temporary hair loss condition triggered by physiological stress.
How hair growth works
Your hair follicles cycle through three phases:
- Anagen (growth phase): Lasts 2-7 years. About 85-90% of your hair is in this phase at any given time.
- Catagen (transition phase): Lasts 2-3 weeks. The follicle shrinks and detaches from the blood supply.
- Telogen (resting phase): Lasts 2-4 months. The hair sits in the follicle, not growing, until it eventually falls out and is replaced by a new anagen hair.
Under normal conditions, only about 10-15% of your hair is in the telogen phase at once. You lose 50-100 hairs per day and barely notice.
What happens during telogen effluvium
When your body experiences significant physiological stress -- rapid weight loss, major caloric restriction, surgery, severe illness, hormonal shifts -- it shifts resources away from non-essential functions. Hair growth is non-essential. The body pushes a larger-than-normal percentage of hair follicles from the anagen phase into the telogen phase simultaneously.
Two to four months later, all those telogen hairs fall out at once. This is when you notice the shedding. It can be alarming -- clumps in the shower, visible thinning, hair coming out when you run your fingers through it.
A 2021 review on telogen effluvium and weight loss (PMID: 34170647) documented this pattern across multiple weight loss modalities. The condition is well-documented after bariatric surgery, where patients lose weight rapidly and experience significant caloric and nutritional restriction. Hair loss rates after bariatric surgery range from 30-60% of patients -- far higher than the 3% seen in semaglutide trials.
This comparison is important. It suggests that the hair loss seen with semaglutide is proportional to the degree of weight loss and caloric restriction, not a unique toxic effect of the drug itself.
Why semaglutide triggers it
Several factors converge to create the conditions for telogen effluvium in semaglutide patients.
Rapid weight loss
Patients on semaglutide 2.4mg lost an average of 14.9% of body weight in 68 weeks in the STEP 1 trial. For a 250-pound person, that is roughly 37 pounds. Much of this loss occurs in the first 6-9 months, which creates the kind of rapid change that triggers telogen effluvium.
The faster the weight loss, the more likely hair shedding becomes. This is true regardless of the method -- medication, surgery, or diet.
Caloric restriction
Semaglutide dramatically reduces appetite. Many patients eat significantly less than they did before starting the medication -- sometimes dropping to 800-1,200 calories per day without intending to. When caloric intake drops substantially, the body enters a conservation mode that deprioritizes hair growth.
Nutritional deficiencies
Eating less means taking in fewer nutrients. Several specific deficiencies are linked to hair loss:
Protein. Hair is made of keratin, a protein. Inadequate protein intake directly impairs hair follicle function. Patients on semaglutide often struggle to eat enough protein because their appetite is so suppressed, and protein-rich foods can feel heavy in a stomach with slowed gastric emptying.
Iron. Iron deficiency (even without frank anemia) is one of the most common causes of hair loss in women. Reduced food intake can easily lead to suboptimal iron levels, especially in premenopausal women.
Zinc. Zinc plays a role in hair tissue growth and repair. Zinc deficiency can cause hair loss and is common in people with restricted diets.
Biotin (Vitamin B7). While severe biotin deficiency is rare, suboptimal levels during caloric restriction may contribute to hair fragility.
Vitamin D. Vitamin D receptors are present in hair follicles, and deficiency is associated with alopecia. Many obese patients start with low vitamin D levels, and reduced food intake can worsen this.
Hormonal shifts
Significant weight loss changes hormonal balance. Fat tissue produces estrogen, and rapid fat loss causes estrogen levels to drop. In women, this hormonal shift can independently contribute to hair shedding. Thyroid function, cortisol levels, and insulin dynamics also shift during major weight changes and can affect the hair growth cycle.
The typical timeline
Understanding when to expect hair loss -- and when to expect it to resolve -- helps reduce the anxiety.
Months 1-3 on semaglutide: Weight loss begins. No hair changes yet. The physiological stress has started, but the hair cycle has a lag.
Months 3-6: This is when shedding typically begins. The telogen hairs pushed into the resting phase 2-4 months ago start falling out. This is when most people first notice increased hair in the shower drain, on their pillow, or on their brush.
Months 6-9: Shedding peaks. This is often the most alarming period. Hair may appear visibly thinner, especially around the temples and crown.
Months 9-12: Shedding begins to slow. New anagen hairs start growing in. The follicles were not damaged -- they were resting. As your body adjusts to its new weight and nutritional intake stabilizes, the hair cycle normalizes.
Months 12-18: For most patients, hair density returns to near-normal. The new hairs may initially be finer or shorter, giving the impression of thinning, but density improves progressively.
This timeline assumes you are maintaining adequate nutrition. If nutritional deficiencies persist, the hair loss can continue or worsen.
What to do about it
Prioritize protein intake
This is the single most important intervention. Aim for at least 1.0-1.2 grams of protein per kilogram of body weight daily (some clinicians recommend up to 1.5g/kg during active weight loss). This can be challenging when your appetite is suppressed. Consider:
- Protein shakes or smoothies (often easier to consume than solid protein when appetite is low)
- Greek yogurt, cottage cheese, eggs
- Lean meats and fish in smaller portions spread throughout the day
- Protein bars as snacks between meals
Get blood work done
Ask your physician to check:
- Ferritin (iron stores -- not just hemoglobin)
- Zinc
- Vitamin D (25-hydroxyvitamin D)
- Thyroid function (TSH, free T4)
- Complete blood count
- Biotin (if available)
Address any deficiencies found. Iron supplementation, in particular, can make a meaningful difference if your ferritin is low (some dermatologists recommend ferritin above 40 ng/mL for optimal hair growth, even if the "normal" range starts lower).
Consider supplementation
A daily multivitamin designed for hair health -- typically containing biotin, zinc, iron, vitamin D, and vitamin C -- may help fill nutritional gaps. Biotin supplementation (2,500-5,000 mcg daily) is commonly recommended by dermatologists for telogen effluvium, though the evidence for supplementation in non-deficient individuals is limited.
Note: biotin supplementation can interfere with certain lab tests (thyroid panels, troponin). Inform your physician if you are taking biotin before any blood work.
Do not crash diet on top of semaglutide
If semaglutide is already reducing your appetite significantly, do not add aggressive caloric restriction on top of it. Eating too little accelerates nutritional depletion and worsens telogen effluvium. Work with your physician or a registered dietitian to ensure you are eating enough to support your body's basic functions, even if the number on the scale moves more slowly.
Slow the weight loss if possible
If hair loss is severe, your physician may consider slowing the dose titration or keeping you at a lower dose where weight loss is more gradual. Losing 1-2 pounds per week is less likely to trigger severe telogen effluvium than losing 3-4 pounds per week.
Be patient
This is the hardest advice but the most important. Telogen effluvium is temporary. The hair follicles are not damaged. They are resting. When the physiological stress stabilizes, they return to the growth phase. Panicking and starting multiple unproven supplements or treatments is usually unnecessary.
When hair loss is not telogen effluvium
Not all hair loss on semaglutide is telogen effluvium. See a dermatologist if:
- Hair loss is patchy (circular bald spots) rather than diffuse thinning -- this could indicate alopecia areata, a different condition
- Hair loss is accompanied by scalp pain, itching, redness, or scarring
- Hair loss does not improve after 12 months despite adequate nutrition
- You had hair thinning before starting semaglutide (could indicate androgenetic alopecia, which has a different cause and treatment)
- Hair loss is accompanied by other symptoms suggesting thyroid dysfunction, autoimmune disease, or hormonal disorders
FAQ
Does everyone lose hair on semaglutide?
No. The clinical trial data indicates that roughly 3% of patients reported hair loss significant enough to be documented as an adverse event. Even accounting for underreporting, the majority of semaglutide users do not experience clinically significant hair loss. Those who lose weight more rapidly and those with pre-existing nutritional deficiencies appear to be at higher risk.
Is hair loss from semaglutide permanent?
In the vast majority of cases, no. Telogen effluvium is a temporary condition. Hair regrowth typically begins within 6-12 months as the body adjusts to its new weight and nutritional intake stabilizes. Permanent hair loss would suggest a different underlying cause and should be evaluated by a dermatologist.
Should I stop semaglutide because of hair loss?
Do not stop any prescribed medication without consulting your physician. Hair loss from telogen effluvium, while distressing, is temporary and not dangerous. The weight loss and metabolic benefits of semaglutide need to be weighed against a temporary cosmetic concern. Your physician can help you make this decision based on your individual situation.
Does tirzepatide cause hair loss too?
Yes. Tirzepatide trials also reported low rates of alopecia, consistent with the telogen effluvium pattern seen across all GLP-1 medications and, more broadly, across all rapid weight loss modalities. The mechanism is the same -- physiological stress from weight loss, not a direct drug effect. See our semaglutide vs tirzepatide comparison for more on how these medications compare.
Bottom line
Semaglutide-associated hair loss is real but almost certainly caused by the rapid weight loss and nutritional changes that accompany the medication -- not a direct toxic effect of the drug. The same pattern occurs after bariatric surgery, crash diets, and any other scenario involving rapid weight loss.
The good news: it is temporary. The fix is not complicated: eat enough protein, address nutritional deficiencies, do not crash diet on top of the medication, and give your body time to adjust. If hair loss is severe or does not resolve, see a dermatologist to rule out other causes.
This article is for educational purposes only and is not medical advice. Always consult a qualified healthcare provider if you are experiencing hair loss or changes in hair density. See our full medical disclaimer.
Sources
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002. PMID: 33567185
- Rebello CJ, Greenway FL. Telogen effluvium and weight loss: a systematic review. Journal of Cosmetic Dermatology. 2021. PMID: 34170647
- Wegovy (semaglutide injection 2.4 mg) -- FDA Prescribing Information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide injection) -- FDA Prescribing Information. U.S. Food and Drug Administration.
- Grover C, Khurana A. Telogen effluvium. Indian Journal of Dermatology, Venereology and Leprology. 2013;79(5):591-603.
- Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatology Practical & Conceptual. 2017;7(1):1-10.
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.